You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Any other non-.GEP-NET

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pulmonary Neuroendocrine Tumor, Pheochromocytoma, Paraganglioma Trial in Houston (177Lu-DOTATOC)

Recruiting
  • Pulmonary Neuroendocrine Neoplasm
  • +9 more
  • Houston, Texas
    Excel Diagnostics and Nuclear Oncology Center
Jul 9, 2021

Following Menopause Treated WithNon-hormonal Therapy for Hot

Not yet recruiting
  • Hot Flashes
  • (no location specified)
Sep 18, 2023

Cervical/Supraclavicular Metastasis From Non-small-cell Lung

Recruiting
  • Lung Cancer Metastatic
  • Needle or forceps biopsy of cervical and/or supraclavicular lymph nodes
  • Needle, forceps or surgical biopsy of any lesion other than cervical and/or supraclavicular lymph nodes
  • Roma, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Jan 23, 2023

A Multi Biomarker Approach In Metastatic GEP NETs

Completed
  • Gastroenteropancreatic Neuroendocrine Tumors
  • This is a non-interventional study. Patients will be treated with any intervention deemed appropriate by the patient's physician.
  • Aarhus, Denmark
  • +24 more
Dec 6, 2021

Well-differentiated Non-functional NET of Thoracic Origin, Well-differentiated Non-functional NET of Gastrointestinal Origin,

Completed
Has Results
  • Well-differentiated Non-functional NET of Thoracic Origin
  • +3 more
  • Duarte, California
  • +34 more
Mar 16, 2021

Colostomy Stoma, Ileostomy - Stoma, Peristomal Skin Complication Trial in Granada (A natural neutral Ecological Extra Virgin

Completed
  • Colostomy Stoma
  • +2 more
  • A natural neutral Ecological Extra Virgin Olive Oil based gel
  • A conventional neutral gel, without Ecological Extra Virgin Olive Oil or any other olive oil-derived products
  • Granada, Spain
  • +1 more
Dec 5, 2022

Lutathera® in Somatostatin Receptor Positive

Recruiting
  • Somatostatin Receptor-positive GEP-NET
  • Lutathera
  • Seongnam Si, Gyeonggi Do, Korea, Republic of
  • +4 more
Jun 29, 2022

Chromogranin A as Blood Marker in Cancer Patients

Completed
  • Gastric Neoplasms
  • +3 more
  • BRAHMS CgA II KRYPTOR
  • Palo Alto, California
  • +3 more
Dec 19, 2022

GEP-NET Trial in Taiwan (nanoliposomal irinotecan plus carboplatin)

Not yet recruiting
  • GEP-NET
  • nanoliposomal irinotecan plus carboplatin
  • Kaohsiung, Taiwan
  • +5 more
May 17, 2022

Neuroendocrine Tumors Trial in Seoul (Lanreotide autogel)

Recruiting
  • Neuroendocrine Tumors
  • Lanreotide autogel
  • Seoul, Korea, Republic of
    Changhoon Yoo
Jul 18, 2022

68Ga-DOTATOC Radio-Guided Surgery With ß-Probe in GEP-NET

Recruiting
  • Neuroendocrine Tumor Carcinoid
  • +2 more
    • Milan, Italy
      IRCCS Istituto Europeo di Oncologia S.r.l.
    Jul 8, 2022

    Small Cell Lung Cancer (SCLC), Large Cell Neuroendocrine Cancer (LCNEC), Neuroendocrine Prostate Cancer (NEPC) Trial (PT217)

    Not yet recruiting
    • Small Cell Lung Cancer (SCLC)
    • +3 more
    • (no location specified)
    Dec 7, 2022

    Gastroenteropancreatico Tumors, Neuroendocrine Tumors, Neuroendocrine Tumors Trial run by the National Cancer Institute (NCI)

    Recruiting
    • Gastroenteropancreatico Tumors
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 19, 2023

    Advanced NSCLC Trial in Worldwide (Pembrolizumab, Favezelimab, Lenvatinib)

    Active, not recruiting
    • Advanced Non-Small Cell Lung Cancer
    • Pembrolizumab
    • +3 more
    • Tempe, Arizona
    • +80 more
    Aug 23, 2022

    Neuroendocrine Tumors - Patient Reported Outcomes

    Enrolling by invitation
    • Neuroendocrine Tumors
    • +3 more
      • Gainesville, Florida
      • +13 more
      Jul 7, 2022

      Acromegaly, GEP-NET Trial in Worldwide (Debio 4126, Sandostatin LAR, Somatuline ATG)

      Recruiting
      • Acromegaly
      • GEP-NET
      • Debio 4126
      • +2 more
      • Copenaghen, Denmark
      • +34 more
      Jan 27, 2023

      Gastro-entero Pancreatic Neuroendocrine Tumors Trial in Italy

      Recruiting
      • Gastro-entero Pancreatic Neuroendocrine Tumors
        • Rozzano, Milan, Italy
        • +35 more
        Oct 27, 2022

        Empagliflozin, Other SGLT-2 Inhibitors, or DPP-4 Inhibitors in

        Completed
        • Diabetes Mellitus, Type 2
        • Subjects treated with Empagliflozin or any Sodium-glucose cotransporter-2 (SGLT-2) inhibitor
        • Subjects treated with Dipeptidyl peptidase-4 (DPP-4) inhibitor
        • Gentofte, Denmark
        • +12 more
        Jan 18, 2022

        GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease Trial in United States

        Recruiting
        • GEP-NET
        • +6 more
        • Duarte, California
        • +3 more
        Jul 28, 2022

        Gastroenteropancreatic Neuroendocrine Tumor Trial in Stanford (Lutathera, Gallium 68 Dotatate, Computed Tomography (CT))

        Suspended
        • Gastroenteropancreatic Neuroendocrine Tumor
        • Stanford, California
          Stanford Cancer Institute Palo Alto
        Sep 21, 2022

        Neuroendocrine Tumors,Gastroenteropancreatic Trial in Taipei (Cabozantinib, Lanreotide)

        Not yet recruiting
        • Neuroendocrine Tumors,Gastroenteropancreatic
        • Taipei, Taiwan
          National Taiwan University Hospital
        Sep 9, 2021

        Neuroendocrine Tumors, Peptide Receptor Radionuclide Therapy Trial in Rotterdam (olaparib)

        Recruiting
        • Neuroendocrine Tumors
        • Peptide Receptor Radionuclide Therapy
        • Rotterdam, South Holland, Netherlands
          Erasmus MC
        May 19, 2023

        Neuroendocrine Tumors Trial in Innsbruck (68Ga-DOTA-MGS5)

        Completed
        • Neuroendocrine Tumors
        • Innsbruck, Austria
          Department of Nuclear Medicine, Medical University of Innsbruck
        Nov 24, 2023

        Neuroendocrine Tumors Trial in Milano (Y90-DOTA-Tyr3-Octreotide)

        Completed
        • Neuroendocrine Tumors
        • Milano, Italy
          Chiara Maria Grana
        Mar 3, 2020

        Gastroenteropancreatic Neuroendocrine Tumours

        Recruiting
        • Gastroenteropancreatic Neuroendocrine Tumor
        • 68Ga-DOTATOC PET as a part of their clinical diagnostic work-up will be included
        • Milano, Italy
          Irccs San Raffaele
        Nov 24, 2023